RHHBY vs MRK
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
RHHBY · ROCHE HOLDING AG$59.37 ▼ 0.13%
MRK · Merck & Co$146.73 ▼ 0.14%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- RHHBY +39.7%
- MRK +73.1%
Head to head
| Metric | RHHBY | MRK |
|---|---|---|
| Price | $59.37 | $146.73 |
| Change today | ▼ 0.13% | ▼ 0.14% |
| Market cap | $333.05B | $361.73B |
| Return, 3 months | +3.4% | +12.1% |
| Return, year to date | +18.8% | +41.4% |
| Return, 1 year | +46.0% | +74.0% |
| P/E (TTM) | 24.6 | 148.2 |
| P/B | 9.5 | 8.1 |
| P/E percentile vs own 5y | – | 95th |
| Dividend yield | 2.61% | 2.32% |
| Revenue growth (YoY, latest qtr) | – | +4.7% |
| Net profit growth (YoY) | – | -12.4% |
| Gross margin | – | 71.8% |
| Operating margin | – | 9.2% |
| Net margin | – | 3.6% |
| Return on equity | – | – |
| Analyst target vs. price | – | +14.1% |
| Analyst buy share | – | 79% |
| RSI (14) | 56 | 51 |
| 30-day volatility | 26.8% | 33.2% |
| Max drawdown, 1 year | -19.3% | -11.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MRK is the largest of the group by market value.
- MRK has returned the most over the past year.
- RHHBY carries the lowest trailing P/E.
- RHHBY pays the highest dividend yield.
- RHHBY has been the calmest stock over the last 30 days.